Replies to post #42009 on $heff's $tation of $tocks & $olid DD

[$heff]

The SEC charged an FDA chemist with insider trading,which generated more than $3.6 million in illicit profits.

SEC alleges that Cheng Yi Liang illegally traded on confidential information about upcoming announcements of FDA drug approval decisions.

Liang traded in advance of at least 27 public announcements about FDA drug approval decisions involving 19 publicly traded companies.

Liang went to great lengths to conceal his insider trading. He traded in seven brokerage accounts, none of which were in his name. One belonged to his 84-year-old mother who lives in China.

Some company stocks that were traded included POZEN, Inc. (Nasdaq: POZN), Mannkind (Nasdaq: MNKD), Vanda (Nasdaq: VNDA), Momenta (Nasdaq: MNTA) and Encysive (Nasdaq: ENCY) among others.

http://www.streetinsider.com/FDA/SEC+Charges+FDA+Employee+With+Insider+Trading/6394431.html?si_nl_click=2011032918-231

These are the trades that the chemist profited from.
http://sec.gov/news/press/2011/2011-76-chart.pdf